FDA Approval of New Alzheimer’s Drug May Boost Prospects of Other Treatments

Joseph Walker with The Wall Street Journal reports, the FDA endorsed a hypothesis about Alzheimer’s that not long ago was thought dead: The disease can be treated by clearing the buildup of a sticky substance in the brain known as amyloid.